Hedge Fund - Cormorant Asset Management
Atea Pharmaceuticals Inc. (AVIR)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2023 - Q3 (2023-09-30) | $0 | 0% | 0 | $3.40 |
| 2 | 2023 - Q2 (2023-06-30) | $5,786,457 | 0.32% | 1,547,181 | $3.74 |
| 3 | 2023 - Q1 (2023-03-31) | $5,183 | 0.34% | 1,547,181 | $4.06 |
| 4 | 2022 - Q4 (2022-12-31) | $7,442 | 0.49% | 1,547,181 | $5.06 |
| 5 | 2022 - Q3 (2022-09-30) | $8,803,000 | 0.61% | 1,547,181 | $7.65 |
| 6 | 2022 - Q2 (2022-06-30) | $10,985,000 | 0.83% | 1,547,181 | $6.83 |
| 7 | 2022 - Q1 (2022-03-31) | $11,171,000 | 0.85% | 1,547,181 | $6.79 |
| 8 | 2021 - Q4 (2021-12-31) | $15,014,000 | 0.89% | 1,679,442 | $15.58 |
| 9 | 2021 - Q3 (2021-09-30) | $172,802,000 | 7.02% | 4,928,756 | $27.74 |
| 10 | 2021 - Q2 (2021-06-30) | $137,716,000 | 4.67% | 6,411,355 | $30.05 |
| 11 | 2021 - Q1 (2021-03-31) | $395,901,000 | 8.81% | 6,411,355 | $67.56 |
| 12 | 2020 - Q4 (2020-12-31) | $259,830,000 | 6.18% | 6,411,355 | $32.23 |
The displayed share prices are average quarterly stock market prices.